VectivBio Holding AG Ordinary Shares
VECT
VECT was delisted on the 7th of July, 2023.
26 hedge funds and large institutions have $270M invested in VectivBio Holding AG Ordinary Shares in 2021 Q2 according to their latest regulatory filings, with 26 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$77.8M |
| 2 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$53.5M |
| 3 |
B
Bpifrance
Maisons Alfort, Cedex,
France
|
+$42.6M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$41.4M |
| 5 |
CA
CHI Advisors
New York
|
+$39.3M |
Top Sellers
VECT Hedge Fund Activity: Q2 2021 in Review
26 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in VectivBio Holding AG Ordinary Shares (VECT) for Q2 2021, worth a combined $270M.
Buyers outnumbered sellers: 26 funds opened new VECT positions and 0 closed out — a net gain of 26 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was OrbiMed, opening a new position worth an estimated $77.8M.
- 26 institutional investors held VectivBio Holding AG Ordinary Shares (VECT) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $270M of VectivBio Holding AG Ordinary Shares stock for Q2 2021.
- 26 funds opened new VectivBio Holding AG Ordinary Shares positions in Q2 2021 and 0 closed out, a net change of +26 holders.
- The largest VectivBio Holding AG Ordinary Shares buyer in Q2 2021 was OrbiMed, an estimated $77.8M added.
Based on aggregated 13F filings for Q2 2021.